ME
McIlrath & Eck’s Oramed Pharmaceuticals ORMP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.25K | Hold |
1,000
| – | – | ﹤0.01% | 826 |
|
2025
Q1 | $2.14K | Hold |
1,000
| – | – | ﹤0.01% | 826 |
|
2024
Q4 | $2.42K | Hold |
1,000
| – | – | ﹤0.01% | 855 |
|
2024
Q3 | $2.44K | Sell |
1,000
-1,000
| -50% | -$2.44K | ﹤0.01% | 843 |
|
2024
Q2 | $5.14K | Hold |
2,000
| – | – | ﹤0.01% | 712 |
|
2024
Q1 | $5.84K | Hold |
2,000
| – | – | ﹤0.01% | 695 |
|
2023
Q4 | $4.62K | Hold |
2,000
| – | – | ﹤0.01% | 684 |
|
2023
Q3 | $5.22K | Sell |
2,000
-500
| -20% | -$1.31K | ﹤0.01% | 646 |
|
2023
Q2 | $8.95K | Sell |
2,500
-500
| -17% | -$1.79K | ﹤0.01% | 582 |
|
2023
Q1 | $6.54K | Hold |
3,000
| – | – | ﹤0.01% | 615 |
|
2022
Q4 | $36.1K | Hold |
3,000
| – | – | 0.01% | 307 |
|
2022
Q3 | $19K | Hold |
3,000
| – | – | 0.01% | 413 |
|
2022
Q2 | $14K | Hold |
3,000
| – | – | ﹤0.01% | 449 |
|
2022
Q1 | $26K | Hold |
3,000
| – | – | 0.01% | 349 |
|
2021
Q4 | $43K | Hold |
3,000
| – | – | 0.01% | 264 |
|
2021
Q3 | $66K | Sell |
3,000
-1,000
| -25% | -$22K | 0.02% | 200 |
|
2021
Q2 | $54K | Buy |
+4,000
| New | +$54K | 0.02% | 222 |
|